ÂÜÀòÂÒÂ×

Daniella Beckman serves as the Chief Financial Officer at Tango Therapeutics since September 2019, overseeing finance, investor relations, and business development. Additionally, Daniella is an active board member at Blueprint Medicines and Vor Biopharma, where Daniella also chairs the Audit Committee. Past board positions include serving as Audit Committee Chair at 5:01 Acquisition Corp and Translate Bio. Prior to their current roles, Daniella was the part-time CFO at Beckman Consulting LLC and held key financial positions at Idenix Pharmaceuticals, Coley Pharmaceutical, Inc., Biogen Idec, Inc., and PricewaterhouseCoopers. Daniella holds a BS in Accounting from the Questrom School of Business, Boston University.